Boston Scientific (NYSE:BSX) landed CE Mark approval in the European Union for its Infinion 16 percutaneous lead, designed for use with the company’s Precision Plus spinal cord stimulator system.
BSX’s spinal cord stimulator leads are designed to mask pain signals to the brain by delivering electrical pulses from an implantable pulse generator.